Welcome to our dedicated page for Csx SEC filings (Ticker: CSX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The CSX Corporation (CSX) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. CSX is a Virginia-incorporated transportation company based in Jacksonville, Florida, operating a Class I railroad network in the eastern United States. Its common stock is listed on the NASDAQ Global Select Market under the symbol CSX, and its filings offer detailed insight into its rail, intermodal and rail-to-truck transload operations.
Through this page, users can review current reports on Form 8-K that CSX files to describe material events. Recent 8-K filings have addressed topics such as leadership transitions in the President and Chief Executive Officer role, appointments of the Executive Vice President and Chief Financial Officer, promotions of senior commercial executives, quarterly financial and operating results, and public offerings of notes due 2035 under the company’s shelf registration statement and long-standing indenture.
In addition to 8-Ks, investors can locate annual reports on Form 10-K and quarterly reports on Form 10-Q, which CSX references in its current reports and press releases. These filings typically contain information on the company’s financial condition, results of operations, risk factors and details about its rail network that connects major metropolitan areas, ports and more than 240 short-line railroads.
Stock Titan enhances these documents with AI-powered summaries that highlight key points from lengthy filings, helping users quickly understand the significance of new debt issuances, executive employment agreements, severance arrangements, or results of operations disclosures. Real-time updates from the EDGAR system ensure that new CSX filings, including Forms 8-K, 10-K, 10-Q and related exhibits, appear promptly, while insider and governance-related information disclosed in proxy materials and other documents can also be explored through this page.
CSX Corp senior vice president and chief commercial officer received a grant of 1,296 shares of common stock on 11/14/2025, reported at a price of $0 per share. These are restricted stock units awarded under the CSX Corporation 2025-2027 Long-Term Incentive Plan and will vest in three equal installments on February 14, 2026, February 14, 2027 and February 14, 2028. After this grant, the executive beneficially owns 7,090 shares directly, 3,372 equivalent shares through the CSX Corporation 401(k) Savings Thrift Plan, and 4,154 shares via a joint revocable trust.
CSX (CSX) insider filing: The SVP & Chief Commercial Officer reported initial beneficial ownership. Direct common stock holdings total 5,794 shares, which include RSUs scheduled to vest beginning on February 14–16, 2026. Indirect holdings include 3,360 shares through the CSX Corporation 401(k) Plan and 4,154 shares held via a Joint Revocable Trust.
Stock options reported include, among others, 22,569 shares at an exercise price of $26.5 expiring on 02/18/2030 and 38,130 shares at $31.24 expiring on 06/02/2032. The event date is 10/29/2025; a Power of Attorney is on file.
CSX Corp (CSX) reported an insider transaction on a Form 4. On 11/03/2025, the company’s President & CEO and Director acquired 254 units of phantom stock (Transaction Code: A) at a derivative security price of $35.83 per unit. The filing states each phantom stock unit is economically equivalent to one share of common stock and will be paid in cash according to the reporting person’s prior distribution election. The holdings are reported as indirect through the CSX Executive Deferred Compensation Plan.
CSX Corporation announced leadership changes. Kevin S. Boone was appointed Executive Vice President and Chief Financial Officer, effective immediately. Boone previously served as Executive Vice President and Chief Commercial Officer since June 2021. He succeeds Sean R. Pelkey, who separated from his role as CFO on October 29, 2025 and, subject to signing a customary separation agreement and release, will be eligible for compensation and benefits under the CSX Executive Severance Plan as described in the 2025 Proxy Statement.
The company also promoted Maryclare T. Kenney to Senior Vice President and Chief Commercial Officer, effective immediately. Kenney has held multiple leadership roles since joining CSX in 2011, including responsibilities across Merchandise Sales and Marketing, TRANSFLO, Automotive and TDSI, and previously led Intermodal and Automotive. CSX furnished a press release as Exhibit 99.1.
CSX Corporation executive EVP & CCO filed a Form 4 reporting option exercises and a same‑day sale on 10/22/2025. The reporting person exercised options for 15,969 shares at $17.59 and 15,084 shares at $17.94, then sold 31,053 shares at a weighted average price of $36.09 (transactions ranged from $36.09 to $36.10).
After these transactions, direct ownership stood at 197,521 shares. Indirect holdings included 1,740 equivalent shares in the CSX Corporation 401(k) plan and 1,500 shares in a spouse’s IRA. Footnotes note a 3‑for‑1 stock split on 06/28/2021 that adjusted option strike prices and share counts, and that direct holdings include 678 shares acquired via the CSX Employee Stock Purchase Plan on 06/30/2025.
CSX Corporation completed a public offering of $300,000,000 aggregate principal amount of its 5.050% Notes due 2035. These Notes constitute a further issuance and will form a single series with the Company’s outstanding $600,000,000 5.050% Notes due 2035 issued on March 10, 2025.
The Notes were issued under CSX’s longstanding Indenture and priced pursuant to an Action of Authorized Pricing Officers dated October 20, 2025. The offering was made from the Company’s automatic shelf registration on Form S-3ASR, with a Prospectus dated February 27, 2025 and a Prospectus Supplement dated October 20, 2025.
CSX Corporation (CSX): An officer (SVP – CLO & Corp Secy) reported stock option exercises and a share sale on 10/20/2025. The filing shows exercises of 13,107 options at $17.94 and 11,142 options at $22.70, followed by a sale of 24,249 common shares at a weighted average price of $36.76 (transactions ranged from $36.76 to $36.77). After these transactions, beneficial ownership was 51,640 shares directly and 1,769 shares indirectly via the CSX Corporation 401(k) Plan. The total also reflects 704 shares acquired under the ESPP and an update correcting prior Form 3 reporting.
CSX Corporation entered into an underwriting agreement for a public offering of $300,000,000 aggregate principal amount of its 5.050% Notes due 2035. These notes are a further issuance that will form a single series with the Company’s outstanding 5.050% Notes due 2035 originally issued on March 10, 2025 in an initial aggregate principal amount of $600,000,000.
The offering was made under CSX’s automatic shelf registration on Form S-3ASR, with a Prospectus dated February 27, 2025 and a Prospectus Supplement dated October 20, 2025. Citigroup, J.P. Morgan, and UBS acted as representatives of the underwriters, who will purchase the notes for resale to the public. Closing is expected on October 23, 2025, subject to customary conditions.
CSX Corporation is offering $300,000,000 aggregate principal amount of 5.050% Notes due 2035. The New Notes are a reopening of the outstanding 5.050% Notes due 2035 and will be fully fungible with the existing series.
The Notes mature on June 15, 2035, pay interest on June 15 and December 15, and, for the New Notes, first pay on December 15, 2025. They are unsecured senior obligations ranking equally with other unsecured senior debt. CSX may redeem the Notes at any time, with a make-whole before the Par Call Date of March 15, 2035 and at 100% thereafter.
The price to the public was 103.069% with a 0.650% underwriting discount. Gross proceeds were $309,207,000 and proceeds to CSX were $307,257,000; CSX estimates net proceeds of approximately $306.9 million after expenses, to be used for general corporate purposes, which may include debt repayments, share repurchases, capital investment and working capital. Upon issuance, total outstanding for this series will be $900,000,000. The Notes will not be listed; settlement is expected T+3.
CSX Corporation reported an insider purchase by its President & CEO (also a Director). On 10/20/2025, the executive purchased 55,000 shares of Common Stock (code P) at a weighted average price of $36.87, bringing direct beneficial ownership to 58,234 shares.
The filing notes the shares were bought in multiple transactions at prices ranging from $36.80 to $36.94, inclusive.